3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Leukemia, Myeloid, Acute
25
Leukemia
13
Neuroblastoma
12
Myelodysplastic Syndromes
12
Multiple Myeloma
12
Recurrence
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma
8
Sarcoma
7
Medulloblastoma
7
Astrocytoma
7
Lymphoma, Non-Hodgkin
6
Wilms Tumor
5
Osteosarcoma
5
Central Nervous System Neoplasms
5
Brain Neoplasms
5
Sarcoma, Ewing
4
Rhabdoid Tumor
4
Retinoblastoma
4
Optic Nerve Glioma
4
Neoplasms
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Burkitt Lymphoma
4
Testicular Neoplasms
3
Interventions
venetoclax
1
vandetanib
1
tremelimumab
1
ricolinostat
1
pomalidomide
1
pembrolizumab
1
pazopanib
1
niraparib
1
ibrutinib
1
enzastaurin
1
durvalumab
1
copanlisib
1
brigatinib
1
binimetinib
1
avasopasem manganese
1
abexinostat
1
Transplantation, Autologous
1
Steroids
1
Melphalan
1
Interleukin-2
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Dexamethasone
1
Blood Specimen Collection
1
Biopsy
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Disease Progression
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT02043847
2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1
Completed
12 enrolled
12 charts